Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.2153
0.00 (0.00%)
At close: Nov 12, 2026
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $16.7 million as of November 20, 2026. It is the 37,707th most valuable company in the world and the 5,194th biggest in the United States. Its market cap has increased by 1,262.66% in one year.
Market Cap
16.70M
Enterprise Value
17.53M
Revenue
n/a
Global Rank
Country Rank
#5,194 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2021, Biomind Labs's market cap has decreased from 18.69M to 16.70M, a decrease of -10.64%. That is a compound annual growth rate of -2.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 16.70M | 88.86% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 22.83M |
| NDT Pharmaceuticals | 20.81M |
| EOM Pharmaceuticals Holdings | 19.99M |
| Provectus Biopharmaceuticals | 18.37M |
| Vicapsys Life Sciences | 16.19M |
| Inhibitor Therapeutics | 13.90M |
| Synlogic | 13.47M |
| Brainstorm Cell Therapeutics | 12.56M |